Citigroup’s Treace Medical Concepts TMCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.39K	Sell	2,533 -11,743	-82%	-$23.4K	﹤0.01%	5345
2025 Q4	$35K	Buy	14,276 +8,404	+143%	+$36.5K	﹤0.01%	4696
2025 Q3	$39.4K	Sell	5,872 -11,636	-66%	-$76K	﹤0.01%	4566
2025 Q2	$103K	Sell	17,508 -17,750	-50%	-$116K	﹤0.01%	4391
2025 Q1	$296K	Sell	35,258 -4,326	-11%	-$38.9K	﹤0.01%	3961
2024 Q4	$295K	Buy	39,584 +4,162	+12%	+$27.8K	﹤0.01%	4158
2024 Q3	$205K	Buy	35,422 +17,923	+102%	+$115K	﹤0.01%	4328
2024 Q2	$116K	Buy	17,499 +9,937	+131%	+$80.3K	﹤0.01%	4138
2024 Q1	$98.7K	Buy	7,562 +1,030	+16%	+$13.7K	﹤0.01%	4302
2023 Q4	$83.3K	Buy	6,532 +6,421	+5,785%	+$64.9K	﹤0.01%	4278
2023 Q3	$1.46K	Sell	111 -14,357	-99%	-$263K	﹤0.01%	5033
2023 Q2	$370K	Buy	14,468 +14,050	+3,361%	+$363K	﹤0.01%	3565
2023 Q1	$10.5K	Sell	418 -222	-35%	-$5.21K	﹤0.01%	4708
2022 Q4	$14.7K	Sell	640 -274	-30%	-$6.31K	﹤0.01%	4712
2022 Q3	$20K	Sell	914 -1,632	-64%	-$31.6K	﹤0.01%	4752
2022 Q2	$37K	Buy	2,546 +957	+60%	+$16.1K	﹤0.01%	4678
2022 Q1	$30K	Sell	1,589 -6,624	-81%	-$129K	﹤0.01%	4955
2021 Q4	$153K	Buy	8,213 +6,899	+525%	+$142K	﹤0.01%	4504
2021 Q3	$35K	Buy	1,314 +484	+58%	+$13.3K	﹤0.01%	4952
2021 Q2	$26K	Buy	+830	New	+$26.4K	﹤0.01%	5165